$1.96 Billion is the total value of Alphabet Inc.'s 59 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 10.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VERV | Verve Therapeutics Inc. | $376,958,000 | +124.8% | 10,974,011 | 0.0% | 19.25% | +111.5% | |
| EQRX Inc. | $235,386,000 | +5.5% | 47,552,687 | 0.0% | 12.02% | -0.7% | ||
| PATH | UiPath Inccl a | $177,406,000 | -30.7% | 14,068,674 | 0.0% | 9.06% | -34.8% | |
| Planet Labs PBC | $173,449,000 | +25.4% | 31,942,641 | 0.0% | 8.86% | +18.0% | ||
| DXCM | Sell | Dexcom Inc | $161,080,000 | -48.4% | 2,000,000 | -52.2% | 8.22% | -51.4% |
| OSCR | Oscar Health Inc.cl a | $119,974,000 | +17.4% | 24,042,864 | 0.0% | 6.13% | +10.5% | |
| SNOW | Snowflake Inccl a | $91,031,000 | +22.2% | 535,604 | 0.0% | 4.65% | +15.0% | |
| LYFT | Lyft Inc | $80,839,000 | -0.8% | 6,138,154 | 0.0% | 4.13% | -6.7% | |
| Buy | Duolingo Inc. | $67,084,000 | +430.5% | 704,444 | +387.7% | 3.43% | +399.4% | |
| Freshworks Inc | $52,342,000 | -1.4% | 4,035,595 | 0.0% | 2.67% | -7.2% | ||
| Robinhood Mkts Inc | $49,778,000 | +22.9% | 4,928,535 | 0.0% | 2.54% | +15.6% | ||
| LYEL | Lyell Immunopharma Inc. | $42,991,000 | +12.4% | 5,865,125 | 0.0% | 2.20% | +5.7% | |
| Benson Hill Inc. | $42,065,000 | 0.0% | 15,352,271 | 0.0% | 2.15% | -5.9% | ||
| RLAY | Relay Therapeutics Inc. | $35,093,000 | +33.6% | 1,568,753 | 0.0% | 1.79% | +25.7% | |
| Gitlab Inc. | $30,394,000 | -3.6% | 593,404 | 0.0% | 1.55% | -9.3% | ||
| DM | Desktop Metal Inc. | $28,616,000 | +17.7% | 11,048,730 | 0.0% | 1.46% | +10.8% | |
| Sell | Velo3d Inc | $19,306,000 | +160.9% | 4,900,000 | -8.6% | 0.99% | +145.3% | |
| ME | 23andMe Holding Co. | $19,267,000 | +15.3% | 6,736,785 | 0.0% | 0.98% | +8.5% | |
| Invivyd Inc. | $17,781,000 | -4.6% | 5,680,785 | 0.0% | 0.91% | -10.2% | ||
| SANA | Sana Biotechnology Inc. | $16,875,000 | -6.7% | 2,812,500 | 0.0% | 0.86% | -12.1% | |
| BEAM | Beam Therapeutics Inc. | $15,321,000 | +23.1% | 321,604 | 0.0% | 0.78% | +15.7% | |
| RAPT | RAPT Therapeutics Inc. | $12,999,000 | +31.8% | 540,270 | 0.0% | 0.66% | +24.1% | |
| GLUE | Monte Rosa Therapeutics Inc. | $11,961,000 | -15.5% | 1,464,015 | 0.0% | 0.61% | -20.4% | |
| ILMN | Illumina Inc. | $10,202,000 | +3.5% | 53,470 | 0.0% | 0.52% | -2.6% | |
| Rani Therapeutics Hldgs Inc. | $6,845,000 | -7.2% | 714,471 | 0.0% | 0.35% | -12.7% | ||
| VERA | Vera Therapeutics Inc.cl a | $6,427,000 | +56.6% | 301,580 | 0.0% | 0.33% | +47.1% | |
| DBTX | Decibel Therapeutics Inc. | $5,661,000 | -17.8% | 1,636,258 | 0.0% | 0.29% | -22.7% | |
| NEWR | New Relic Inc. | $5,229,000 | +14.6% | 91,132 | 0.0% | 0.27% | +7.7% | |
| Science 37 Holdings Inc. | $5,164,000 | -19.9% | 3,207,260 | 0.0% | 0.26% | -24.6% | ||
| VACC | Vaccitech PLCads | $4,844,000 | -28.1% | 1,513,644 | 0.0% | 0.25% | -32.5% | |
| KRON | Kronos Bio Inc. | $4,818,000 | -8.0% | 1,438,232 | 0.0% | 0.25% | -13.4% | |
| MGTA | Magenta Therapeutics Inc. | $4,708,000 | +17.5% | 3,339,138 | 0.0% | 0.24% | +10.6% | |
| FHTX | Foghorn Therapeutics Inc. | $4,298,000 | -36.9% | 500,901 | 0.0% | 0.22% | -40.8% | |
| Tscan Therapeutics Inc. | $3,285,000 | -3.0% | 1,077,080 | 0.0% | 0.17% | -8.7% | ||
| Amplitude Inc | $2,931,000 | +8.3% | 189,447 | 0.0% | 0.15% | +2.0% | ||
| Tenaya Therapeutics Inc. | $2,656,000 | -48.5% | 915,705 | 0.0% | 0.14% | -51.4% | ||
| EVLO | Evelo Biosciences Inc. | $2,216,000 | -1.0% | 1,060,495 | 0.0% | 0.11% | -6.6% | |
| FULC | Fulcrum Therapeutics Inc. | $2,066,000 | +65.0% | 255,452 | 0.0% | 0.10% | +54.4% | |
| SPRO | Spero Therapeutics Inc. | $1,780,000 | +170.1% | 889,979 | 0.0% | 0.09% | +152.8% | |
| ALEC | Alector Inc. | $1,664,000 | -6.9% | 175,866 | 0.0% | 0.08% | -12.4% | |
| AUTL | Autolus Therapeutics PLCspon adr | $1,494,000 | -24.4% | 698,262 | 0.0% | 0.08% | -29.0% | |
| TSHA | Taysha Gene Therapies Inc. | $1,237,000 | -48.1% | 640,882 | 0.0% | 0.06% | -51.2% | |
| EXAS | Exact Sciences Corp | $754,000 | -17.5% | 23,205 | 0.0% | 0.04% | -22.0% | |
| Hyperfine Inc. | $728,000 | -63.7% | 898,720 | 0.0% | 0.04% | -66.1% | ||
| NVTA | Invitae Corp | $529,000 | +0.4% | 215,965 | 0.0% | 0.03% | -6.9% | |
| OPRT | Oportun Finl Corp | $414,000 | -47.2% | 94,788 | 0.0% | 0.02% | -51.2% | |
| CRTX | Quince Therapeutics Inc | $252,000 | -40.0% | 189,122 | 0.0% | 0.01% | -43.5% | |
| Cue Health Inc | $81,000 | -5.8% | 27,000 | 0.0% | 0.00% | -20.0% | ||
| RGEN | Repligen Corp | $72,000 | +16.1% | 383 | 0.0% | 0.00% | +33.3% | |
| Exit | WeWork Inccl a | $0 | – | -63,645 | -100.0% | -0.02% | – | |
| S | Exit | Sentinelone Inccl a | $0 | – | -21,231 | -100.0% | -0.03% | – |
| Exit | Enjoy Technology Inc | $0 | – | -4,345,340 | -100.0% | -0.05% | – | |
| OMIC | Exit | Singular Genomics Systems Inc | $0 | – | -586,584 | -100.0% | -0.12% | – |
| IDYA | Exit | Ideaya Biosciences Inc | $0 | – | -753,187 | -100.0% | -0.56% | – |
| Exit | Toast Inccl a | $0 | – | -1,432,660 | -100.0% | -1.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
| AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
| Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
| DEXCOM INC | 20 | Q3 2023 | 17.4% |
| Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
| ALECTOR INC | 19 | Q3 2023 | 1.1% |
| Lyft Inc | 18 | Q2 2023 | 51.9% |
| QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
| Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
| FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 10-Q | 2024-04-26 |
| 144 | 2024-04-26 |
| 4 | 2024-04-26 |
| 4 | 2024-04-26 |
| ARS | 2024-04-26 |
| DEF 14A | 2024-04-26 |
| DEFA14A | 2024-04-26 |
| 8-K | 2024-04-25 |
| 144 | 2024-04-17 |
| 144 | 2024-04-17 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.